MSTN and atherosclerosis: We previously recognized Mstn as a mediator of atherosclerosis progression and vascular inflammation [13]; more recently, Mstn enhancement has been observed also in the tubulointerstitial compartment of the human kidney during diabetic nephropathy, suggesting its contribution to renal interstitial fibrosis [14].